|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Nutrition in chronic pancreatitis显示文摘The pancreas is a major player in nutrient digestion.In chronic pancreatitis both exocrine and endocrine insufficiency may develop leading to malnutrition over time.Maldigestion is often a late complication of chronic pancreatic and depends on the severity of the underlying disease.The severity of malnutrition is correlated with two major factors:(1)malabsorption and depletion of nutrients(e.g.,alcoholism and pain)causes impaired nutritional status;and(2)increased metabolic activity due to the severity of the disease.Nutritional deficiencies negatively affect outcome if they are not treated.Nutritional assessment and the clinical severity of the disease are important for planning any nutritional intervention.Good nutritional practice includes screening to identify patients at risk,followed by a thoroughly nutritional assessment and nutrition plan for risk patients.Treatment should be multidisciplinary and the mainstay of treatment is abstinence from alcohol,pain treatment,dietary modifications and pancreatic enzyme supplementation.To achieve energy-end protein requirements,oral supplementation might be beneficial.Enteral nutrition may be used when patients do not have sufficient calorie intake as in pylero-duodenalstenosis,inflammation or prior to surgery and can be necessary if weight loss continues.Parenteral nutrition is very seldom used in patients with chronic pancreatitis and should only be used in case of GI-tract obstruction or as a supplement to enteral nutrition. | Henrik Hφjgaard Rasmussen φivind Irtun Sφren Schou Olesen Asbjφrn Mohr Drewes Mette Holst | 2013 | World Journal of Gastroenterology2013，19，42： | 4 |
| 2 | Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors显示文摘 | Christina B. Rasmussen Mette T. Faber Allan Jensen Estrid H?gdall Claus H?gdall Jan Blaak?r Susanne K. Kjaer | 2013 | Cancer Causes & Control2013，，7： | 2 |
| 3 | Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants 显示文摘 | Mett V Shamloul AM Hirai H | 2007 | Transgenic Res2007，16，1： | 1 |
| 4 | Outer memnane permeability and β-lactamase content in Pseudomonasmaltophia clinical isolates and laboratory mutants显示文摘 | Mett H Rosta S Schacher B | 1988 | Rev Infect Dis1988，10，4： | 1 |
| 5 | Inhibition of the Abl protein tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative显示文摘 | Buchdunger E Zimmermann J Mett H | 1996 | Cancer Res1996，56，1： | 1 |
| 6 | Making bio-sense of toxicity: new developments in whole-cell biosensors显示文摘 | S?ren J S?rensen Mette Burm?lle Lars H Hansen | 2006 | Current Opinion in Biotechnology2006，，1： | 1 |
| 7 | Inhibition of the ABL protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative 显示文摘 | Buchdunger E Zimmermann J Mett H | 1996 | Cancer Res1996，56，1： | 1 |
| 8 | Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin 显示文摘 | Engelbert M Mino de Kaspar H Mette M Thiel M Ta CN Grasbon T | 2003 | Graefes Arch Clin Exp Ophthalmol2003，241，12： | 1 |
| 9 | Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative显示文摘 | Zimmermann J Mett H | 1996 | Cancer Res1996，56，1： | 1 |
| 10 | Outer membane permeability and β-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants 显示文摘 | Mett H Rosta S Schacher B | 1988 | Rev Infect Dis1988，10，4： | 1 |
| 11 | Graphene-based Composite Materials 显示文摘 | Sasha Stankovich Dmitriy A Dikin Geoffrey H B Dom- mett | 2006 | Nature2006，442，： | 1 |
| 12 | A self-contained, programmable microfluidic cell culture system with real-time microscopy access 显示文摘 | PEDER S P METTE H DAVID S | 2012 | Biomed Microdevices2012，14，： | 1 |
| 13 | Endotracheal suc- tioning of the adult intubated patient-what is the evi- dence显示文摘 | Carsten M Mette N Jeanette H el al | 2009 | Intensive and Critical Nursing2009，25，1： | 1 |
| 14 | Phenylamimo-pyrimidine (PAP) derivatives:a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitors显示文摘 | Zimmermann J Buchdunger E Mett H | 1996 | Bioorg Med Chem Lett1996，6，11： | 1 |
| 15 | Influence of environmental stimuli on nest building and farrowing behaviour in domestic sows 显示文摘 | Karen T Karin H J Mette S H | 1999 | Appl Anim Behav Sci1999，63，2： | 1 |
| 16 | Differentialexpression of cytochrome P450 genes betweenbromadioloneresistant and anticoagulant-susceptible Norwayrats:a possible role for pharmacokinetics in bromadioloneresistance显示文摘 | Mette D K Ann-Charlotte H Merete F | 2008 | Pest Manag Sci2008，64，： | 1 |
| 17 | 4-(Phenylamino) pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase显示文摘 | Traxler P Furet P Mett H | 1996 | J Med Chem1996，39，12： | 1 |
| 18 | Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative显示文摘 | Buchdunger E Zimmermann J Mett H | 1996 | Cancer Res1996，56，1： | 1 |
| 19 | Long-Term Outcome of Delayed Primary or Early Secondary Reconstruction of the Anal Sphincter after Obstetrical Injury显示文摘 | Mette M. Soerensen Karl M. Bek Steen Buntzen Karen-Elise H?jberg S?ren Laurberg | 2008 | Diseases of the Colon & Rectum2008，，3： | 1 |
| 20 | A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo 显示文摘 | Lydon NB Mett H Mueller M | 1998 | Int J Cancer1998，76，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员